Blood pressure drug associated with lower risk of Alzheimer’s disease in Black patients

Considering how patients from different ethnic groups respond to the same drug could be crucial to finding new Alzheimer’s disease treatments – a disorder the Alzheimer’s Association previously deemed a “silent epidemic” among Black adults.